Myomo (MYO) Cash from Operations (QoQ) (2016 - 2025)
Myomo (MYO) Cash from Operations (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 79.37% |
| Jun 30, 2025 | -231.18% |
| Mar 31, 2025 | -179.53% |
| Dec 31, 2024 | 325.26% |
| Sep 30, 2024 | 22.01% |
| Jun 30, 2024 | 40.97% |
| Mar 31, 2024 | -37.77% |
| Dec 31, 2023 | -37.38% |
| Sep 30, 2023 | -500.58% |
| Jun 30, 2023 | 84.28% |
| Mar 31, 2023 | 26.28% |
| Dec 31, 2022 | 11.95% |
| Sep 30, 2022 | -5.69% |
| Jun 30, 2022 | -14.01% |
| Mar 31, 2022 | -25.70% |
| Dec 31, 2021 | 15.65% |
| Sep 30, 2021 | 35.51% |
| Jun 30, 2021 | -60.78% |
| Mar 31, 2021 | -86.47% |
| Dec 31, 2020 | 37.06% |